Table 3.
Imaging modality | All patients (n=165) | Clinical improvement* (n=86) | Clinical deterioration† (n=40) |
NCCT‡ | |||
Symptomatic ICH | 0/120 (0%) | 0/50 (0%) | 0/38 (0%) |
Asymptomatic ICH | 1/120 (1%) | 0/50 (0%) | 0/38 (0%) |
CTA§ | |||
Persistent LVO | 67/124 (54%) | 36/86 (42%) | 10/13 (77%) |
Same segment | 55/124 (44%) | 28/86 (33%) | 8/13 (62%) |
Distal migration | 11/124 (9%) | 8/86 (9%) | 2/13 (15%) |
New vascular territory | 1/124 (1%) | 0/86 (0%) | 0/13 (0%) |
LVO resolved | 57/124 (46%) | 50/86 (58%) | 3/13 (23%) |
*Median Δ NIHSS score between PSC and CSC: −5 (−8 to −2).
†Median Δ NIHSS score between PSC and CSC: 6 (3 to 9).
‡NCCT was repeated in 120/165 patients (73%); 50/86 (58%) of patients with clinical improvement and 38/40 (95%) of patients with clinical deterioration.
§CTA was repeated in 124/165 patients (75%); all patients with clinical improvement and 13/40 (33%) of patients with clinical deterioration.
CSC, comprehensive stroke center; CTA, CT angiography; ICH, intracranial hemorrhage; LVO, large vessel occlusion; NCCT, non-contrast CT; PSC, primary stroke center.